References
- Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Chem 2007;282:28175–88
- Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687–94
- Bozaoglu K, Segal D, Shields KA, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009;94:3085–8
- Ernst MC, Issa M, Goralski KB, et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010;151:1998–2007
- Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009;58:2731–40
- Rani PR, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagn Res 2016;10:QE01–4
- Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 Suppl 2:B161–7
- Garces MF, Sanchez E, Ruiz-Parra AI, et al. Serum chemerin levels during normal human pregnancy. Peptides 2013;42:138–43
- Fatima SS, Alam F, Chaudhry B, et al. Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus. J Matern Fetal Neonatal Med 2016;29:1–6
- Li XM, Ji H, Li CJ, et al. Chemerin expression in Chinese pregnant women with and without gestational diabetes mellitus. Ann Endocrinol (Paris) 2015;76:19–24
- Hare KJ, Bonde L, Svare JA, et al. Decreased plasma chemerin levels in women with gestational diabetes mellitus. Diabet Med 2014;31:936–40
- Dai ZY, Liu D, Li R, et al. [Association between gestational weight gain per trimester/total gestational weight gain and gestational diabetes mellitus]. Zhonghua Liu Xing Bing Xue Za Zhi 2016;37:1336–40
- Lin PC, Hung CH, Chan TF, et al. The risk factors for gestational diabetes mellitus: a retrospective study. Midwifery 2016;42:16–20
- Davenport MH, Campbell MK, Mottola MF. Increased incidence of glucose disorders during pregnancy is not explained by pre-pregnancy obesity in London, Canada. BMC Pregnancy Childbirth 2010;10:85
- van Leeuwen M, Opmeer BC, Zweers EJ, et al. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 2010;117:69–75
- Morisset AS, St-Yves A, Veillette J, et al. Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes Metab Res Rev 2010;26:17–25
- Garnaes KK, Morkved S, Salvesen O, et al. Exercise training and weight gain in obese pregnant women: a randomized controlled trial (ETIP Trial). PLoS Med 2016;13:e1002079
- El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011;28:1194–200
- Sell H, Divoux A, Poitou C, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010;95:2892–6
- Garces MF, Sanchez E, Acosta BJ, et al. Expression and regulation of chemerin during rat pregnancy. Placenta 2012;33:373–8
- Kasher-Meron M, Mazaki-Tovi S, Barhod E, et al. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy. J Perinat Med 2014;42:371–8
- Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005;280:34661–6
- Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485–91
- Pfau D, Stepan H, Kratzsch J, et al. Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 2010;74:56–61
- Barker G, Lim R, Rice GE, et al. Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity. J Matern Fetal Neonatal Med 2012;25:2274–80
- Stepan H, Philipp A, Roth I, et al. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept 2011;168:69–72
- Hart R, Greaves DR. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010;185:3728–39
- Chakaroun R, Raschpichler M, Kloting N, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2012;61:706–14
- Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010;72:342–8
- Kloting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506–15